Huge trial backs cardiac resynchronization therapyCombined ICD-CRT device cuts mortality and heart failure hospitalizations Wireless feedback aids BP controlPatient involvement is key to the success of telemonitoring, say Canadian researchers Rivaroxaban takes off as alternative to warfarin ROCKET AF trial suggests drug offers more user-friendly anticoagulation in atrial fibrillation Rosiglitazone: new Canadian restrictions Health Canada has issued new usage restrictions for rosiglitazone-containing products. Concomitant PPIs and antiplatelet agents OK Pharmacy BP screening lowers hospitalizations Ontario’s Cardiovascular Health Awareness Program targeted community-dwelling seniors Huge Canadian trial backs cardiac resynchronization therapy Combined ICD-CRT device cuts mortality and heart failure hospitalizations Oral contraceptives may stiffen the arteries European score yields mixed results in Canadian trial Guidelines highlight cutting-edge AF treatments Role of recently approved drugs outlined in new atrial fibrillation recommendations First Previous 79 80 81 82 83 Next Last
